Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital

Abstract

ObjectiveTo evaluate the type, acceptance rate, and clinical relevance of clinical pharmacist recommendations at the geriatric ward of the Ghent university hospital.MethodsThe clinical pharmacist evaluated drug use during a weekly 2-hour visit for a period of 4 months and, if needed, made recommendations to the prescribing physician. The recommendations were classified according to type, acceptance by the physician, prescribed medication, and underlying drug-related problem. Appropriateness of prescribing was assessed using the Medication Appropriateness Index (MAI) before and after the recommendations were made. Two clinical pharmacologists and two clinical pharmacists independently and retrospectively evaluated the clinical relevance of the recommendations and rated their own acceptance of them.ResultsThe clinical pharmacist recommended 304 drug therapy changes for 100 patients taking a total of 1137 drugs. The most common underlying drug-related problems concerned incorrect dose, drug–drug interaction, and adverse drug reaction, which appeared most frequently for cardiovascular drugs, drugs for the central nervous system, and drugs for the gastrointestinal tract. The most common type of recommendation concerned adapting the dose, and stopping or changing a drug. In total, 59.7% of the recommendations were accepted by the treating physician. The acceptance rate by the evaluators ranged between 92.4% and 97.0%. The mean clinical relevance of the recommendations was assessed as possibly important (53.4%), possibly low relevance (38.1%), and possibly very important (4.2%). A low interrater agreement concerning clinical relevance between the evaluators was found: kappa values ranged between 0.15 and 0.25. Summated MAI scores significantly improved after the pharmacist recommendations, with mean values decreasing from 9.3 to 6.2 (P < 0.001).ConclusionIn this study, the clinical pharmacist identified a high number of potential drug-related problems in older patients; however, the acceptance of the pharmacotherapy recommendations by the treating physician was lower than by a panel of evaluators. This panel, however, rated most recommendations as possibly important and as possibly having low relevance, with low interrater reliability. As the appropriateness of prescribing seemed to improve with decreased MAI scores, clinical pharmacy services may contribute to the optimization of drug therapy in older inpatients.

Effect of pharmacist‐led medication review on medication appropriateness in older adults with chronic kidney disease

“…The observed reduction in MAI after physicians’ acceptance of pharmacist recommendations was comparable to other hospital studies that evaluated medication appropriateness in older adults using the MAI . However, this reduction is much lower than that observed from medication review studies in community settings .…”

Hospital pharmacist interventions in a central hospital

“…Clinical pharmacy is defined as the provision of patient-oriented pharmaceutical care, with the goals of maximising drug efficacy and minimising drug harm by preventing drug-related problems 1. Clinical pharmacy has been practised in most European countries for several years 2. The clinical and economic impact of clinical pharmacy has been addressed in many studies, and the value of clinical pharmacy has been shown by the improvement in both clinical and economic outcomes 3–8.…”

“…They analyse patients’ pharmacotherapy profiles in relation to their medical and laboratory data. When appropriate, they recommend drug therapy changes to physicians and nurses, and answer questions about drugs 2. Pharmacists routinely make clinical interventions in order to improve the health outcomes of patients 10.…”

Interações medicamentosas potenciais entre pacientes idosos internados em um hospital universitário

“…Os medicamentos mais utilizados, segundo classificação ATC, foram do sistema digestório e metabólico, sistema cardiovascular, antiinfecciosos gerais para uso sistêmico e sistema nervoso, corroborando com Somers e colaboradores 19 . 25 mostraram que os medicamentos envolvidos com RAM induzidas por IM, de acordo com a classificação ATC, são do sistema nervoso (32,0%) e sistema cardiovascular (27,0%).…”